Literature DB >> 15247705

Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter.

Pierre Damiao Gonçalves1, Miguel Srougi, Marcos Francisco Dall'lio, Kátia Ramos Moreira Leite, Valdemar Ortiz, Flávio Hering.   

Abstract

PURPOSE: Renal cell carcinoma is a tumor with unpredictable behavior and defining reliable prognostic factors would be extremely valuable in the clinical setting. Tumor stage, nuclear grade and tumor cell type are the main prognostic clinical parameters available. In this study we evaluated the role of microvascular involvement in the primary lesion for predicting tumor behavior in patients with low stage clinical disease.
MATERIALS AND METHODS: A total of 95 patients with clinically localized renal cell carcinoma (stages T1-T2 Nx M0) underwent radical nephrectomy and/or nephron sparing surgery, and were followed for a median of 45 months. The impact of microvascular tumor invasion on disease progression and its correlation with known pathological outcomes (tumor size, nuclear grade and cell type) were studied.
RESULTS: Microvascular tumor invasion was observed in 24 patients (25%), of whom 50% had disease recurrence. Of the 71 patients without microvascular invasion only 4 (6%) showed tumor recurrence. When microvascular invasion was correlated with other histological parameters, a significant statistical association was noted with tumor diameter, perirenal fat invasion, macroscopic extension to the renal vein, nuclear grade, lymph node metastasis and sarcomatous elements in the tumor. Multivariate analysis showed that microvascular invasion and the involvement of regional lymph nodes were independent predictors of disease recurrence. Concerning cancer specific survival, microvascular invasion and perirenal fat infiltration were the only factors related to death.
CONCLUSIONS: Microvascular invasion is an independent and relevant clinical prognostic parameter for low clinical stage renal cell carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 15247705     DOI: 10.1097/01.ju.0000130582.31467.30

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Microvascular invasion as a prognostic indicator in renal cell carcinoma: a systematic review and meta-analysis.

Authors:  Hai Huang; Xiu-Wu Pan; Yi Huang; Dan-Feng Xu; Xin-Gang Cui; Lin Li; Yi Hong; Lu Chen; Yi Gao; Lei Yin
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Characteristics of aggressive variants in T1a renal cell carcinoma.

Authors:  Tatsuya Takayama; Takayuki Sugiyama; Fumitake Kai; Takahisa Suzuki; Masahiro Nagata; Takeshi Imanishi; Takuji Mizuno; Shigenori Sato; Hiroshi Furuse; Soichi Mugiya; Seiichiro Ozono
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-28       Impact factor: 4.553

3.  Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma.

Authors:  Brian Shuch; Gennady Bratslavsky; Joanna Shih; Srinivas Vourganti; David Finley; Brandon Castor; Eric Treat; W Marston Linehan; Allan J Pantuck; Jonathan W Said; Arie S Belldegrun
Journal:  BJU Int       Date:  2012-01-05       Impact factor: 5.588

4.  Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer.

Authors:  Sabine Brookman-Amissah; Matthias May; Knut Albrecht; Thomas Herrmann; Jan Roigas; Christian Peter Gilfrich; Sandra Pflanz; Sven Gunia
Journal:  World J Urol       Date:  2009-05-29       Impact factor: 4.226

5.  The human renal lymphatics under normal and pathological conditions.

Authors:  Y Ishikawa; Y Akasaka; H Kiguchi; Y Akishima-Fukasawa; T Hasegawa; K Ito; M Kimura-Matsumoto; S Ishiguro; H Morita; S Sato; S Soh; T Ishii
Journal:  Histopathology       Date:  2006-09       Impact factor: 5.087

6.  Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma.

Authors:  Keiichi Ito; Kenji Seguchi; Hideyuki Shimazaki; Eiji Takahashi; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Tomohiko Asano
Journal:  Oncol Lett       Date:  2014-11-04       Impact factor: 2.967

7.  Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study.

Authors:  Yongquan Tang; Zhihong Liu; Jiayu Liang; Ruochen Zhang; Kan Wu; Zijun Zou; Chuan Zhou; Fuxun Zhang; Yiping Lu
Journal:  BMC Urol       Date:  2018-12-06       Impact factor: 2.264

8.  Computerized Image Analysis of Tumor Cell Nuclear Morphology Can Improve Patient Selection for Clinical Trials in Localized Clear Cell Renal Cell Carcinoma.

Authors:  In Hwa Um; Lindesay Scott-Hayward; Monique Mackenzie; Puay Hoon Tan; Ravindran Kanesvaran; Yukti Choudhury; Peter D Caie; Min-Han Tan; Marie O'Donnell; Steve Leung; Grant D Stewart; David J Harrison
Journal:  J Pathol Inform       Date:  2020-11-06

9.  Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.

Authors:  L Campbell; B Jasani; K Edwards; M Gumbleton; D F R Griffiths
Journal:  Br J Cancer       Date:  2008-02-19       Impact factor: 7.640

10.  Evaluation of microvascular invasion as a prognostic factor in the progression of non-metastatic renal cancer.

Authors:  Rubén G Bengió; Leandro Cristian Arribillaga; Javier Epelde; Sergio Orellana; Ariel Montedoro; Verónica Bengió; Esteban Cordero; Matías Guevara
Journal:  Cent European J Urol       Date:  2018-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.